Mar 1, 2022 · The PORTEC-3 trial stipulated that the radiotherapy contouring and planning should follow the guidelines published by the Radiation Therapy Oncology Group (RTOG) as a consensus document [6]. Treatment could be delivered using three-dimensional conformal radiotherapy (3DCRT) or intensity-modulated radiotherapy if available.
Читать далее
View the Menu of Al portec pizzeria in Manerba del Garda, Lombardia, Italy. Share it with friends or find your next meal. Pizzeria con Ristorante, area bimbi, aria condizionata, ampio parcheggio esterno.
Oct 13, 2024 · Franklin - The Future of Variant Interpretation. The most advanced way for variant classification, a FREE comprehensive interpretation tool by Genoox. Try it - search any variant
Читать далее
Nov 18, 2020 · The PORTEC-3 trial showed that patients with stage III disease who received chemoradiation therapy followed by four cycles of carboplatin and paclitaxel chemotherapy had better overall and 5-year ...
Читать далее
Feb 22, 2023 · (Proactive Molecular Risk Classifier for Endometrial Cancer,ProMisE)Tans-PORTEC ，，。 。 ，
Читать далее
Aug 28, 2024 · PORTEC-4A is a multicentre phase III trial comparing adjuvant therapy regimens comprising either molecularly integrated risk-based recommendations (such as observation, VBT or EBRT) with standard ...
Читать далее
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer. / van den Heerik, Anne Sophie V M; Horeweg, Nanda; Nout, Remi A et al. In: International Journal of Gynecological Cancer, Vol. 30, No. 12, 12.2020, p. 2002-2007.
Читать далее
Oct 10, 2020 · Purpose: The randomized Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3) trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy (CTRT) versus radiotherapy alone (RT) for women with high-risk endometrial cancer (EC). Because The Cancer Genome Atlas defined …
Читать далее
Sep 1, 2015 · PORTEC-3 was an open-label, international, randomised, phase 3 trial involving 103 centres in six clinical trials collaborating in the Gynaecological Cancer Intergroup. Eligible women had high-risk endometrial cancer with FIGO 2009 stage I, endometrioid-type grade 3 with deep myometrial invasion or lymph-vascular space invasion (or both ...
Читать далее
Иран-это очень важный рынок Ближнего Востока. Каждый год…
больш
